Prevalence of risk factors for venous thromboembolism in the Italian population: Results of a cross-sectional study from the Master Registry

Internal and Emergency Medicine

Volumn 8, Issue 7, 2013, Pages 575-580

  Ageno, Walter ^a   Agnelli, Giancarlo ^b   Imberti, Davide ^c   Moia, Marco ^d   Palareti, Gualtiero ^e   Pistelli, Riccardo ^f   Verso, Melina ^b  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

^c UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^d FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^e UNIVERSITY OF BOLOGNA   (Italy)

^f CATHOLIC UNIVERSITY   (Italy)

Author keywords

Age; Gender; Risk factors; Unprovoked venous thrombosis; Venous thromboembolism

Indexed keywords

ADULT; AGED; ARTICLE; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; ITALY; MALE; MIDDLE AGED; MULTICENTER STUDY; PREVALENCE; PROSPECTIVE STUDY; REGISTER; RISK FACTOR; VENOUS THROMBOEMBOLISM; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; ITALY; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; REGISTRIES; RISK FACTORS; VENOUS THROMBOEMBOLISM;

EID: 84884534200     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-011-0644-1     Document Type: Article

References (13)

1. Anderson FA Jr, Wheeler HB, Goldberg RJ, Hosmer DW, Patwardan NA, Jovanovic B, Forcier A, Dalen DE (1991) A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism: the Worcester DVT Study. Arch Intern Med 151: 933-938.
2. Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton J III (1998) Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 158: 585-593.
3. Schulman S, Lindmarker P, Holmström M, Lärfars G, Carlsson A, Nicol P, Svensson E, Ljungberg B, Viering S, Nordlander S, Leijd B, Jahed K, Hjorth M, Linder O, Beckman M (2006) Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months. J Thromb Haemost 4: 734-742.
4. Kearon C, Iorio A, Palareti G (2010) Subcommittee on Control of Anticoagulation of the SSC of the ISTH. Risk of recurrent venous thromboembolism after stopping treatment in cohort studies: recommendation for acceptable rates and standardized reporting. J Thromb Haemost 8: 2313-2315.
5. White RH (2003) The epidemiology of venous thromboembolism. Circulation 107: I4-I8.
6. Agnelli G, Verso M, Ageno W, Imberti D, Moia M, Palareti G, Rossi R, Pistelli R, MASTER investigators (2008) The MASTER registry on venous thromboembolism: description of the study cohort. Thromb Res. 12: 605-610.
7. Cogo A, Bernardi E, Prandoni P, Girolami B, Noventa F, Simioni P, Girolami A (1994) Acquired risk factors for deep-vein thrombosis in symptomatic outpatients. Arch Intern Med 154: 164-168.
8. Hansson PO, Welin L, Tibblin G, Eriksson H (1997) Deep vein thrombosis and pulmonary embolism in the general population. The Study of Men Born in 1913. Arch Intern Med 157: 1665-1670.
9. Nordstrom M, Lindblad B, Bergqvist D, Kjellstrom T (1992) A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med 232: 155-160.
10. Oger E (2000) Incidence of venous thromboembolism: a community-based study in western France. Thromb Haemost 83: 657-660.
11. Rosendaal FR (1999) Venous thrombosis: a multicausal disease. Lancet 353: 1167-1173.
12. Steffen LM, Cushman M, Peacock JM, Heckbert SR, Jacobs DR, Rosamond WD, Folsom AR (2009) Metabolic syndrome and risk of venous thromboembolism: longitudinal investigation of thromboembolism etiology (LITE). J Thromb Haemost 7: 746-751.
13. Kearon C, Kahn SR, Agnelli G et al (2008) Antithrombotic therapy for venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 133: 454-545.